Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Cancer Prev Res (Phila). 2012 Feb 16;5(4):612–620. doi: 10.1158/1940-6207.CAPR-11-0548

Fig. 2. API-1 downregulates c-FLIP levels without increasing DR4 and DR5 expression.

Fig. 2

A, The given cell lines were treated with 5μM API-1 for 24 h. B, H157 cells were treated with different concentrations of API-1 as indicated for 12 h. C, H157 cells were treated with 5μM API-1 for the indicated times. After the aforementioned treatments, the cells were subjected to preparation of whole-cell protein lysates and subsequent Western blot analysis for the given proteins. LE, longer exposure.